Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zai Lab (ZLAB) Treasury Shares: 2021-2025

Historic Treasury Shares for Zai Lab (ZLAB) over the last 5 years, with Sep 2025 value amounting to $29.1 million.

  • Zai Lab's Treasury Shares rose 39.44% to $29.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $29.1 million, marking a year-over-year increase of 39.44%. This contributed to the annual value of $20.8 million for FY2024, which is negligibly% changed negligibly from last year.
  • As of Q3 2025, Zai Lab's Treasury Shares stood at $7.4 million, which was up 51.08% from $4.9 million recorded in Q2 2025.
  • Zai Lab's Treasury Shares' 5-year high stood at $7.4 million during Q3 2025, with a 5-year trough of $60,860 in Q2 2021.
  • For the 3-year period, Zai Lab's Treasury Shares averaged around $5.0 million, with its median value being $4.9 million (2025).
  • Data for Zai Lab's Treasury Shares shows a peak YoY surged of 1,104.44% (in 2022) over the last 5 years.
  • Zai Lab's Treasury Shares (Quarterly) stood at $4.3 million in 2021, then soared by 177.07% to $11.9 million in 2022, then soared by 75.74% to $20.8 million in 2023, then remained steady at $20.8 million in 2024, then soared by 39.44% to $29.1 million in 2025.
  • Its Treasury Shares stands at $29.1 million for Q3 2025, versus $20.9 million for Q2 2025 and $20.8 million for Q1 2025.